HYF
Immunoprecise Antibodies
HYFT • NASDAQ
Immunoprecise Antibodies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer Lynne Bath, with a market cap of $52.3M.
Market Cap$52.3M
Employees102.0
CEOJennifer Lynne Bath
CountryCanada
Healthcare
Biotechnology
Financials
HYF
Immunoprecise Antibodies FAQ
Common questions about Immunoprecise Antibodies
Immunoprecise Antibodies has approximately 102 employees.